M&A Deal Summary

Teva Pharmaceutical Industries Acquires Sicor

On January 22, 2004, Teva Pharmaceutical Industries acquired life science company Sicor from Ferrer Freeman for 3.4B USD

Acquisition Highlights
  • This is Teva Pharmaceutical Industries’ 4th transaction in the Life Science sector.
  • This is Teva Pharmaceutical Industries’ 6th largest (disclosed) transaction.
  • This is Teva Pharmaceutical Industries’ 2nd transaction in the United States.
  • This is Teva Pharmaceutical Industries’ 1st transaction in California.

M&A Deal Summary
Date 2004-01-22
Target Sicor
Sector Life Science
Buyer(s) Teva Pharmaceutical Industries
Sellers(s) Ferrer Freeman
Deal Type Add-on Acquisition
Deal Value 3.4B USD
Advisor(s) Bear Stearns & Co. Inc. (Financial)

Target

Sicor

Irvine, California, United States
Sicor, Inc. is a vertically integrated specialty pharmaceutical company with expertise in the development, manufacturing and marketing of generic injectable pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teva Pharmaceutical Industries

Tel Aviv, Israel
Category Company
Founded 1901
Sector Life Science
Employees35,001
Revenue 15.8B USD (2023)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.

DEAL STATS #
Overall 4 of 23
Sector (Life Science) 4 of 20
Type (Add-on Acquisition) 3 of 19
State (California) 1 of 4
Country (United States) 2 of 15
Year (2004) 1 of 1
Size (of disclosed) 6 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-06-25 Honeywell Pharmaceutical Fine Chemicals S.r.l.

Bulciago, Italy

Honeywell Pharmaceutical Fine Chemicals S.r.l. is a manufacturer of pharmaceutical drugs and sundries.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-07-26 Ivax

Miami, Florida, United States

Ivax Corp. is a develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products.

Buy $7.4B

Seller(S) 1

SELLER

Ferrer Freeman

Greenwich, Connecticut, United States
Category Private Equity Firm
Founded 1995
PE ASSETS 900M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Ferrer Freeman & Co. (FFC) is a private equity firm that invests exclusively in healthcare companies generating sales minimum $20 to $200 million. FFC also invests in clinical products and outsourcing/infrastructure businesses serving the healthcare sector. FFC looks to commit $10 to $40 million per transaction and focuses primarily on growth capital financings and build-ups. However, the Firm will also selectively fund buyouts as well. Ferrer Freeman & Co. LLC was formed in 1995 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 2 of 24
Sector (Life Science) 1 of 4
Type (Add-on Acquisition) 1 of 15
State (California) 1 of 4
Country (United States) 2 of 24
Year (2004) 1 of 2
Size (of disclosed) 1 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-04-07 Xcel Pharmaceuticals

San Diego, California, United States

Xcel Pharmaceuticals, Inc. is a commercial-based specialty pharmaceutical company focused on the treatment of disorders of the central nervous system (CNS).

Buy $26M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-07-01 GeneraMedix Pharmaceuticals

Libert Corner, New Jersey, United States

GeneraMedix Pharmaceuticals, based in Liberty Corner, New Jersey, is an international generic pharmaceutical company primarily focused on the development and sale of injectable products utilized in hospitals and specialty clinics.

Buy -
Mergr

Product

Company

Legal